About (1S,4S)-5-(2-phenyltriazole-4-carbonyl)-2-oxa-5-azabicyclo[2.2.1]heptan-3-one
(1S,4S)-5-(2-phenyltriazole-4-carbonyl)-2-oxa-5-azabicyclo[2.2.1]heptan-3-one (PubChem CID 95985271) has the molecular formula C14H12N4O3
and a molecular weight of 284.27 g/mol. Its IUPAC name is (1S,4S)-5-(2-phenyltriazole-4-carbonyl)-2-oxa-5-azabicyclo[2.2.1]heptan-3-one.
Analyze (1S,4S)-5-(2-phenyltriazole-4-carbonyl)-2-oxa-5-azabicyclo[2.2.1]heptan-3-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (1S,4S)-5-(2-phenyltriazole-4-carbonyl)-2-oxa-5-azabicyclo[2.2.1]heptan-3-one?
The IUPAC name of (1S,4S)-5-(2-phenyltriazole-4-carbonyl)-2-oxa-5-azabicyclo[2.2.1]heptan-3-one (CID 95985271) is (1S,4S)-5-(2-phenyltriazole-4-carbonyl)-2-oxa-5-azabicyclo[2.2.1]heptan-3-one.
What is the SMILES notation for (1S,4S)-5-(2-phenyltriazole-4-carbonyl)-2-oxa-5-azabicyclo[2.2.1]heptan-3-one?
The canonical SMILES for (1S,4S)-5-(2-phenyltriazole-4-carbonyl)-2-oxa-5-azabicyclo[2.2.1]heptan-3-one is O=C1O[C@H]2C[C@@H]1N(C(=O)c1cnn(-c3ccccc3)n1)C2.
What is the InChIKey of (1S,4S)-5-(2-phenyltriazole-4-carbonyl)-2-oxa-5-azabicyclo[2.2.1]heptan-3-one?
The InChIKey is KXODVPBXWSYOGB-JQWIXIFHSA-N. The full InChI is InChI=1S/C14H12N4O3/c19-13(17-8-10-6-12(17)14(20)21-10)11-7-15-18(16-11)9-4-2-1-3-5-9/h1-5,7,10,12H,6,8H2/t10-,12-/m0/s1.
What are the key properties of (1S,4S)-5-(2-phenyltriazole-4-carbonyl)-2-oxa-5-azabicyclo[2.2.1]heptan-3-one?
(1S,4S)-5-(2-phenyltriazole-4-carbonyl)-2-oxa-5-azabicyclo[2.2.1]heptan-3-one has a molecular weight of 284.27 g/mol, XLogP of 0.41, 2 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,4S)-5-(2-phenyltriazole-4-carbonyl)-2-oxa-5-azabicyclo[2.2.1]heptan-3-one is sourced from PubChem (CID 95985271), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).